“…(Bell et al, 2018;Gaskin et al, 2014;LaVeist, Pollack, Thorpe, Fesahazion, & Gaskin, 2011) Themes of toxicology ring true for the clinical impact of SDOH, namely, that there is individual variation in susceptibility that is influenced by the dose, timing, and duration of SDOH exposures. Both individual and neighborhood level SDOH risks are associated with hypertensive disorders during pregnancy (Stanhope, Adeyemi, Li, Johnson, & Boulet, 2021) and perinatal outcomes (Bangma, Hartwell, Santos, O'Shea, & Fry, 2021;Burris et al, 2020;DiTosto, Holder, Soyemi, Beestrum, & Yee, 2021), and hospital discharge practices (Hudson, 2021). With regards to neonatal outcomes and childhood development, the timing of SDOH factors, such as medical insurance coverage of prenatal care, has critical consequences on preterm birth rates and, in general, perinatal outcomes are worse for Medicaid-insured patients.…”